CureVac N.V.
CVAC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $739 | $840 | $1,065 | $5,612 |
| - Cash | $482 | $402 | $496 | $811 |
| + Debt | $39 | $42 | $42 | $29 |
| Enterprise Value | $296 | $479 | $611 | $4,830 |
| Revenue | $535 | $54 | $67 | $103 |
| % Growth | 895.5% | -20.3% | -34.5% | – |
| Gross Profit | $429 | -$71 | -$117 | -$135 |
| % Margin | 80.2% | -131.3% | -172.9% | -131.3% |
| EBITDA | $210 | -$234 | -$209 | -$386 |
| % Margin | 39.2% | -435.5% | -310.6% | -375.3% |
| Net Income | $162 | -$260 | -$249 | -$412 |
| % Margin | 30.3% | -484% | -369.4% | -399.8% |
| EPS Diluted | 0.72 | -1.18 | -1.32 | -2.21 |
| % Growth | 161% | 10.6% | 40.3% | – |
| Operating Cash Flow | $102 | -$268 | -$286 | -$733 |
| Capital Expenditures | -$18 | -$55 | -$93 | -$128 |
| Free Cash Flow | $83 | -$323 | -$379 | -$861 |